PMID: 11910661Mar 26, 2002Paper

Selective estrogen receptor modulators: tissue selectivity and differential uterine effects

Climacteric : the Journal of the International Menopause Society
S L SilfenH U Bryant

Abstract

Selective estrogen receptor modulators (SERMs) are compounds that bind to estrogen receptors and produce estrogen-like (agonist) effects in some tissues and estrogen-blocking (antagonist) effects in other tissues. One of the goals of SERM research has been to develop compounds that provide the potential benefits of estrogen in the skeleton and cardiovascular system, but avoid the negative effects of estrogen in other tissues. Estrogen therapy has been consistently associated with endometrial stimulation, including glandular proliferation, hyperplasia and cancer. In contrast, the presence or degree of endometrial stimulation observed with SERMs varies by compound. The purpose of this review is to differentiate the endometrial effects of compounds that display a SERM-like profile. Molecular mechanisms involving SERM binding to estrogen receptors, preclinical uterine effects in both tissue culture and animal models, and endometrial findings in clinical experience are discussed. There are several SERMs commercially available or in development. The favorable safety profile of raloxifene in the uterus differentiates it from the others. Future SERM development will continue to focus on finding compounds that exhibit minimal endometria...Continue Reading

References

Dec 4, 1975·The New England Journal of Medicine·H K Ziel, W D Finkle
Jan 1, 1979·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·V A Drill
Dec 4, 1975·The New England Journal of Medicine·D C SmithW L Herrmann
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P F Bruning
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·P K ChakrabortyA S Mitchell
Jan 1, 1991·American Journal of Clinical Oncology·J Bellmunt, L Solé
Jan 1, 1991·American Journal of Clinical Oncology·U EppenbergerW Küng
Jan 1, 1990·Pharmacology & Therapeutics·J E Hart
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·S KallioR Toivola
Dec 1, 1983·The Journal of Endocrinology·A E Wakeling, B Valcaccia
Feb 1, 1995·Obstetrics and Gynecology·D GradyD Petitti
Sep 1, 1994·Journal of Clinical Pathology·S M Ismail
Feb 1, 1994·American Journal of Obstetrics and Gynecology·S R Goldstein
Jan 1, 1996·Gynecologic Oncology·T KakuH Nakano
Jun 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M SatoH U Bryant
Aug 1, 1996·Carcinogenesis·P CarthewL L Smith
Nov 1, 1996·Drug and Chemical Toxicology·S KarlssonG M Williams
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·P S CookeG R Cunha
Jun 1, 1997·Regulatory Toxicology and Pharmacology : RTP·J AshbyJ R Foster
Aug 8, 1997·The Journal of Biological Chemistry·S M CowleyM G Parker

❮ Previous
Next ❯

Citations

Jun 30, 2001·Obstetrics and Gynecology·S R GoldsteinL Plouffe
Oct 11, 2003·Urology·Dudley Robinson, Linda D Cardozo
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Dalia Somjen, Israel Yoles
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Dudley Robinson, Linda Cardozo
May 13, 2010·Reproductive Biology and Endocrinology : RB&E·J Alejandro Arreguin-ArevaloTerry M Nett
Oct 29, 2009·Journal of Hematology & Oncology·Ruirong YuanDavid Lebwohl
Jul 31, 2014·PloS One·Valentina Elisabetta Viviana FerreroTeresa Lettieri
Dec 3, 2013·Pharmacology & Therapeutics·Todd P Knutson, Carol A Lange
Jan 1, 2008·Obstetrics and Gynecology·Pamela StrattonLynnette K Nieman
Mar 3, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Hua ZhuYu-Mei Shen
Apr 13, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Dalia SomjenIsrael Yoles
May 15, 2007·Nuclear Medicine and Biology·Jai Woong SeoJohn A Katzenellenbogen
Jul 16, 2003·American Journal of Obstetrics and Gynecology·Michael D VardyFelicia Cosman
Mar 21, 2002·American Journal of Obstetrics and Gynecology·Lesley N OttoRobert M Brenner
Jan 26, 2005·The Journal of the British Menopause Society·John O L DeLancey
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Ov D SlaydenRobert M Brenner
Sep 9, 2010·The Cochrane Database of Systematic Reviews·Sharif I IsmailSuzanne Hagen
May 12, 2021·The Cochrane Database of Systematic Reviews·Maaike Ht van HoeselSelma M Mourad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved